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Abstract
Klebsiella oxytoca, a member of the Enterobacteriaceae, is a gram-negative pathogenic bacterium of environmental origin, which
can cause infection in healthcare settings. Outbreaks of multidrug-resistant K. oxytoca infection have been increasingly reported in
hospitalized patients. Despite the growing importance of this pathogen, there is limited knowledge about the population structure
and epidemiology of antimicrobial resistantK. oxytoca. We investigated the population structure and genomic basis of antimicrobial
resistance of 41 multidrug resistant K. oxytoca isolates recovered from bloodstream infections across the UK and Ireland. Our
results show that K. oxytoca has a highly diverse population, which is composed of several distinct clades, and we identified one
recent expansion of a clone within our dataset. Although the K. oxytoca genomes are clearly distinct from the genomes of a global
collection of Klebsiella pneumoniae complex, pre-dominantly composed of K. pneumoniae, we found evidence for sharing of core
genes through recombination, as well as the exchange of accessory antimicrobial resistance and virulence factor genes between
the species. Our findings also suggest that the different K. oxytoca clades have acquired antimicrobial resistance and virulence
factorgenes independently.Thishighlights theclinicalandtherapeutic importanceofgeneticflexibility inK.oxytocaandtherelevance
of this in its role as an opportunistic pathogen.
Key words: microbial genomics, antimicrobial resistance, population genomics, genomic epidemiology.
Introduction
Klebsiella oxytoca is an important member of the genus
Klebsiella, which contains species that cause nosocomial and
community acquired infections worldwide (Bagley 1985;
Broberg et al. 2014; Podschun and Ullmann 1998).
Originating from the environment, K. oxytoca typically resides
in the intestinal tract as a commensal bacterium but can
spread to the bloodstream and cause disease, in particular in
patients with a compromised immune system (Al-Anazi et al.
2008; Tang and Chen 1995). Klebsiella oxytoca outbreaks
generally have environmental sources, and are subsequently
propagated by the dissemination of the pathogen in
healthcare settings, for example, in transplant, intensive
care, or neonatal units (Bagley 1985; Decre et al. 2004;
Lowe et al. 2012; Zarate et al. 2008). Furthermore, outbreaks
of K. oxytoca usually involve strains with extended-spectrum
beta-lactamases and carbapenamases (Decre et al. 2004;
Lowe et al. 2012; Schulz-Stubner and Kniehl 2011; Zarate
et al. 2008), which enable bacterial resistance to beta-
lactam antibiotics and consequently lead to therapeutic prob-
lems (Wu et al. 1991, 1999). The mechanisms of resistance
may involve either the over-expression of constitutive beta-
lactamase genes or the presence of multiple copies of beta-
lactamase genes, both of which result in the over-production
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of beta-lactamase enzymes (Gheorghiu et al. 1997; Paterson
and Bonomo 2005). Klebsiella oxytoca has also been reported
to exhibit resistance to other commonly used antibiotics, such
as fluoroquinolones and tetracyclines (Brisse et al. 2000).
The genomes of several K. oxytoca isolates have recently
been sequenced, showing that the bacterial genome is 5Mbp
in length and contains 5,488 protein-coding genes (Shin et al.
2012). Some of these isolates were recovered from environ-
mental sources (Chen et al. 2013; Lu et al. 2015) and the ge-
nomic data was generated in order to better understand their
ability to produce specific chemicals, which are very useful in-
dustrial raw materials, for example, ethanol and 1,3-propane-
diol, in bioreactors and fuel production (Dien et al. 2003; Zhang
et al. 2012). The sequencing of clinical K. oxytoca revealed a
combination of putative virulence, antibiotic resistance and
metabolic genes that provide the species with the genetic rep-
ertoire to survive and transmit within the human host and over-
come specific challenges in the clinical habitat, including
antibiotic treatment (Liao et al. 2012). Moreover the few pre-
viously sequenced genomes ofK. oxytocawere shown to share
some virulence genes with K. pneumoniae (Jiang et al. 2014),
suggesting that the two closely related pathogenic species may
share a common gene pool providing similar virulence and re-
sistance mechanisms. However, due to the lack of population
level data the insights that such studies on individual genomes
of K. oxytoca can provide are limited. Furthermore, the popu-
lation diversity of antimicrobial resistance and virulence genes,
as well as the global population structure of K. oxytoca, is
largely unknown. To address these, we utilized the whole
genome sequencing of a nationwide systematic collection of
multidrug resistantK. oxytoca isolated from bloodstream infec-
tions in theUKand Ireland inorder to investigate thepopulation
diversity and occurrence of antimicrobial resistance determi-
nants across the population. Our findings indicate that the K.
oxytoca population is highly diverse and comprised of several
distinct clades, one of which had evidence for recent expan-
sion. Besides the emergence of species-specific resistance
genes, our results also show similarities between K. oxytoca
and the global K. pneumoniae complex population (Holt
et al. 2015) and identify common virulence and antibiotic re-
sistancemechanisms thathavebeenacquired inoneorotherof
the species.
Materials and Methods
Isolates and Antimicrobial Susceptibility Testing
Approval to conduct the study was obtained from the
Research Ethics Service (ref: 12/EE/0439) of the United
Kingdom and the Cambridge University Hospitals (CUH)
Research and Development (R&D) Department. Forty-one K.
oxytoca isolates were collected by the British Society for
Antimicrobial Chemotherapy (BSAC) as part of a systematic
bacteremia surveillance programme between 2001 and 2011
by 20 hospitals across the United Kingdom and Ireland (UK&I).
A list of isolates, along with accession numbers for the geno-
mic data, is provided in supplementary table S1,
Supplementary Material online. We also analyzed the collec-
tion by placing it in the context of previously published K.
oxytoca genomes. To conduct a comparative study between
the K. oxytoca population and the global K. pneumoniae com-
plex population, which is predominantly composed of K.
pneumoniae, we utilized the genomes from a published
global K. pneumoniae complex study (Holt et al. 2015).
Susceptibility to a wide range of antimicrobials was exam-
ined in this study. This included the beta-lactams; penicillins
(amoxicillin, amoxicillin–clavulanate and piperacillin–tazobac-
tam) and cephalosporins (cefuroxime, cefoxitin, cefotaxime
and ceftazidime) and other antibiotics such as tetracyclines
(minocycline, tetracycline and tigecycline), an aminoglycoside
(gentamicin), and a fluoroquinolone (ciprofloxacin). The min-
imum inhibitory concentration (MIC) for each of the isolates
was generated using the agar dilution method (Andrews
2001), as described in the protocol available on the BSAC
surveillance programme website (www.bsacsurv.org/proto-
cols/; MICs obtained by the BSAC agar dilution were shown
to be in good agreement with the MICs from the broth micro-
dilution method, Reynolds et al. 2003). The distributions for
the antimicrobials were then compared with the distributions
for those antimicrobials given on the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) website (the dis-
tributions of MICs for K. oxytoca were the same as those for
Raoultella ornithinolytica). The EUCAST distributions, as well as
the clinical breakpoints for K. oxytoca were downloaded from
the EUCAST website on 10/01/2017.
Sequencing and Pan-Genome Analysis
DNA was extracted with the QIAxtractor (QIAgen) kit ac-
cording to the manufacturer’s instructions. Subsequently
we prepared Illumina sequencing libraries with a 450 bp
insert size, as detailed in the manufacturer’s protocol,
and performed sequencing on an Illumina HiSeq2000
with paired-end reads of length 100 bp. We multiplexed
96 samples per lane to attain an average depth of cover-
age of 85-fold. An assembly improvement pipeline (Page
et al. 2016) based on Velvet (Zerbino and Birney 2008)
was used to obtain de novo genome assemblies. The as-
semblies were annotated with Prokka (Seemann 2014).
The output of Prokka was used as input for the pan-
genome pipeline Roary (Page et al. 2015), which pro-
duced a list of genes in the core and accessory
genome. We have submitted the output files of Roary
and the sequences of the genes in the pan-genome to
a public repository (www.data.mendeley.com/datasets/
z4n3sbszgb/1).
We identified SNPs in the core genome alignment of K.
oxytoca using an in-house tool (www.github.com/sanger-
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pathogens/snp-sites). We mapped the short reads from both
the global K. pneumoniae complex collection and our K. oxy-
toca isolates to the reference genome K. oxytoca KCTC (ac-
cession number: CP003218), with SMALT v0.7.4 (www.
sanger.ac.uk/science/tools/smalt-0) with maximum and mini-
mum inserts sizes of 1,000 and 50, respectively. We then
employed SAMtools mpileup (Li et al. 2009) and BCFtools,
as described in (Harris et al. 2010), to annotate SNPs. To this
end, we considered SNPs that were supported by at least two
forward and two reverse reads. We employed a minimum
base call quality of 50 and a minimum root mean squared
mapping quality of 30 to call a SNP. We excluded the SNPs
at sites with heterogeneous mapping in which the SNP was
present in <75% of reads at that site, similar to Harris et al.
(2010). To construct the multiple alignment, we ignored the
small indels and produced pseudo-sequences. The pseudo-se-
quences were then used to construct a multiple alignment of
the collection. We used the same tool, as described above for
the core-genome alignment, to extract SNPs from the multiple
alignment.
To obtain aMaximum Likelihood tree, FastTree version2.1.3
was used with generalized time-reversible model to calculate
the phylogenetic tree from the alignments, after ignoring sites
with unknown bases (Price et al. 2010). We used iTOL (Letunic
and Bork 2016), FigTree (www.tree.bio.ed.ac.uk/software/fig-
tree/) and Dendroscope (Huson and Scornavacca 2012) to vi-
sualize the results and compare the patternof the presence and
absence of accessory gene with the core genome content. We
calculated both the pairwise SNP distances and the Average
Nucleotide Identity (ANI) to measure population diversity. To
calculate the ANI values, we employed the online server that is
available at www.enve-omics.ce.gatech.edu/ani/ with the de-
fault parameter values and submitted the assemblies to the
server. We used the ANI calculator to obtain the maximum
and minimum divergences between pairs of isolates from the
MDR K. oxytoca and each sub-species of the global K. pneu-
moniae complex collection (Holt et al. 2015) with the largest
pairwise SNP distances. We also calculated the ANI values for
the pairs of isolates within K. oxytoca and the global collection
with the largest pairwise SNP distance value to obtain the max-
imum and minimum boundaries for the genomic diversity
within each species.
In Silico MLST Analysis and Identification of Antimicrobial
Resistance Determinants, Virulence Factors, and Plasmids
We employed the srst2 package (Inouye et al. 2014), with the
coverage cut-off of 90%, to screen the short reads for known
resistance genes and plasmid replicons within the dataset.
Identification of the variants of the blaoxy gene allowed us to
identify the major phylogroups of K. oxytoca (Fevre et al.
2005). To compare the distribution of virulence genes in the
K. oxytoca and the global K. pneumoniae complex collection,
we downloaded the sequences of putative virulence factors
from the BIGSdb-Kp database (Bialek-Davenet et al. 2014),
available on the Pasteur institute website (http://bigsdb.pas-
teur.fr/perl/bigsdb/bigsdb.pl?db=pubmlst_klebsiella_seqdef_
public&page=downloadAlleles) and used these as reference
sequences for srst2. We only used those genes which have
a previously published link with virulence in K. pneumoniae.
We identified STs of the isolates by performing in silico MLST
with an in-house tool (https://github.com/sanger-pathogens/
mlst_check) that takes genome assemblies.
Phylogenetic and Recombination Analysis and
Substitution Rate Calculation
After identifying the phylogenetic structure of the MDR K.
oxytoca population, we extracted isolates within the ST2
clade and mapped the short reads to the concatenated con-
tigs of the isolate with the best assembly statistics, that is, the
highest N50 value. The mapping and SNP calling was done as
described above and a multiple alignment, which includes
5,607 SNPs, was reconstructed from pseudo-genomes.
We then identified high-SNP density blocks, representing
recent recombination, with Gubbins (Croucher et al. 2015)
using five iterations. Because Gubbins is known to work
best for closely related isolates, we ran the tool only for the
ST2 clade, which was found to be the largest recent clade in
our collection. We then extracted the recombined regions and
identified the genes that occurred in them. We searched the
NCBI non-redundant nucleotide database using BLAST with
the extracted recombinant sequences to identify the likely
donor species of the recombined DNA. We also compared
the results from Gubbins with those from ClonalFrameML
(Didelot and Wilson 2015), which calculates Maximum
Likelihood estimates at every site to identify recombinant frag-
ments. For this programme, we used the relative transition
versus tranversion rate of two and utilized the default priors
for the gamma distribution in the program.
After removing the recombinant regions and reconstruct-
ing the phylogenetic tree, the root-to-tip distance was com-
puted and plotted against the isolation year to assess the
temporal signal. We conducted 1,000 bootstrap tests to eval-
uate the significance of the R-squared value, which was found
to be greater than 80% of R-squared values from the boot-
straps for the ST2 clade.
Subsequently we analyzed the data with BEAST v1.7
(Drummond and Rambaut 2007), testing various models
that included a constant size population with strict molecular
clock (with a log-normal distribution for base frequencies) and
a GTR model with a gamma correction for among site varia-
tion. We then performed three independent chains for 50
million generations with sampling every ten generations. To
control the convergence, we used the Effective Sample Size
(ESS) values, defining convergence as ESS>200, after exclud-
ing 10 million initial states as burn-in. We found that the strict
clock model always converged and therefore we based our
Population Structure of Multidrug-Resistant K. Oxytoca GBE
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results on the estimates from this model in this study. We used
the TreeAnnotator tool available in the BEAST package to
obtain the Bayesian tree and confidence intervals (CIs) for
node ages.
Results
We first investigated the population structure of the MDR K.
oxytoca isolates based on whole genome diversity. The pop-
ulation of K. oxytoca appears to consist of two major clades,
both of which contain distinct sub-clades. Some of these sub-
clades appear to have expanded recently within the studied
population, suggesting recent dissemination of the pathogen
(fig. 1A). It is known that the variants of the chromosomally
encoded beta-lactamase-OXY define major phylogroups of
this species, and the evolution of blaoxy was thought to have
occurred congruently with the evolution of K. oxytoca (Fevre
et al. 2005). In line with this, we found that four variants of
blaoxy (blaOXY1, blaOXY2, blaOXY6, and blaOXY5) are present in
the isolates and correspond to the phylogenetic groups KoI,
KoII, KoVI, and KoV on the whole genome tree, respectively
(fig. 1A). A comparison between phylogenetic trees for the
core genome and the blaoxy gene demonstrates that the trees
are congruent for the major phylogroups (see supplementary
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FIG. 1.—(A) Maximum Likelihood phylogenetic tree for the MDR Klebsiella oxytoca collection. Hosp. and ST stand for hospital of isolation and sequence
type, respectively. The background colours signify the major phylogroups of K. oxytoca. (B) Combined phylogenetic tree of the global Klebsiella pneumoniae
complex (Kp) collection and the MDR K. oxytoca (Ko) collection. The background colours correspond to the species within the global K. pneumoniae complex
collection. KpI, KpII and KpIII correspond toK. pneumoniae,Klebsiella quasipneumoniae, andKlebsiella variicola, respectively. (C) Distribution of SNP distances
for pairs of K. oxytoca and the whole K. pneumoniae complex (Kp) and each species within the K. pneumoniae complex. The values have been divided by the
genome length of reference genome used for mapping. The boxes give the interquartile range and the whiskers indicate the boundary of 1.5 times the
interquartile range. The white marker shows the median of the data and the coloured area is the probability density of the data at different values. (D)
Distributions of pairwise SNP distances for the K. oxytoca collection and the global K. pneumoniae complex.
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fig. S1A, Supplementary Material online). However, within the
KoII clade the blaoxy tree shows some incongruency with the
core genome. This within phylogroup incongruency may be
due to recent recombination, and is also apparent for other
core genes like rpoB and dnaA (see supplementary fig. S1B
and C, Supplementary Material online), demonstrating that
blaoxy behaves like a true core gene. The majority of isolates
are from KoII, and form one of the major clades, followed by
KoI, which along with KoVI and KoV form the other major
clade. KoV seems to be a closely related sister-group to KoI
(fig. 1A). Our findings confirm that blaoxy has a single common
origin within K. oxytoca, and underwent vertical evolution
within the major phylogenetic groups, as previously proposed
(Fevre et al. 2005).
Previously published genomes of clinical K. oxytoca were
from isolates pre-dominantly recovered from hospitals in the
United States and therefore do not represent the global diver-
sity of K. oxytoca. However, the phylogenetic distribution of
the MDR K. oxytoca from our collection and the other avail-
able genomes indicates that the previously published ge-
nomes are interspersed with the UK&I isolates across the
phylogenetic tree and within every major phylogroup.
Indeed, K. oxytoca isolates collected from a single hospital’s
intensive care units are spread across KoII, KoVI, KoI, and KoV
(Roach et al. 2015; see supplementary fig. S2A,
Supplementary Material online). Moreover, the genomes of
two non-clinical isolates recovered from China are mixed with
KoVI MDR isolates (Bao et al. 2013; Chen et al. 2013), and one
environmental isolate from South Korea (Shin et al. 2012), one
isolate recovered from panda faeces in China (Jiang et al.
2014), and one from a soap product in Germany (Hammerl
et al. 2015) all appear to be closely related to MDR isolates in
the KoI clade (see supplementary fig. S2A, Supplementary
Material online). Some of the inter-country relationships that
we identified in the KoI clade appear to share most recent
common ancestors within the past few decades (see supple-
mentary fig. S2B, Supplementary Material online), suggesting
a global circulation of K. oxytoca. These results indicate that
the MDR K. oxytoca within the collection from the UK&I are
both highly diverse and linked to isolates of widely different
origins and isolation sites. In addition, we found evidence that
clinical isolates of K. oxytoca can be closely related to non-
clinical isolates, suggesting the environment can serve as a
potential reservoir for K. oxytoca.
To compare the population diversity of our collection with
that of K. pneumoniae as the most closely related pathogen
(Brisse and Verhoef 2001), we placed our collection in the
context of a global K. pneumoniae complex population,
which was dominated by K. pneumoniae (Holt et al. 2015;
fig. 1B). A phylogenetic tree constructed from the two collec-
tions confirmed the complete separation between the species.
The MDR K. oxytoca isolates appeared to be equally distant to
each of the sub species of the K. pneumoniae complex, with a
SNP distance/genome length of around 0.1 for the K. oxytoca
genomes to each of the species of K. pneumoniae complex
within the global collection (fig. 1C). In line with this, the ANI
values between the two most closely and distantly related
isolates from the MDR K. oxytoca and the global K. pneumo-
niae complex collection were 83.43% and 83.53%, respec-
tively. Moreover, we found that MDR K. oxytoca was more
diverse than K. pneumoniae complex species KpI (K. pneumo-
niae), KpII (K. quasipneumoniae) and KpIII (K. variicola) and the
whole global K. pneumoniae complex collection, even though
the MDRK. oxytoca collection was limited to clinical facilities in
the UK and Ireland (fig. 1D). The ANI values for the most
distantly related isolates seemed to be smaller for the MDR
K. oxytoca (90.97%) than for the whole K. pneumoniae com-
plex and each species within the collection (99.18%, 98.96%,
98.93%, and 92.87% for KpI, KpII, KpIII, and the whole K.
pneumoniae complex populations, respectively). The low ANI
value across the breadth of K. oxytoca isolates suggests that,
similar to the global K. pneumoniae complex collection, which
was split into three distinct species corresponding to the major
phylogroups, defined by the major clades, the K. oxytoca spe-
cies may need to be redefined and split into multiple species,
defined by the major clades that we have identified here.
In line with our finding of high diversity within K. oxytoca,
we found that the collection was composed of 16 STs, of
which only ST2, ST36, ST34, ST88, ST9, and ST50 were rep-
resented by >2 isolates. ST2 and ST9 are known to belong to
a globally expanding beta-lactam resistant clonal complex
(CC)2, implying again that our collection is part of a globally
circulating K. oxytoca population (Izdebski et al. 2015). The
clade representing ST2 appears to have undergone recent
expansion in our collection (figs. 1A and 2). The temporal
signal within ST2 allowed us to determine the nucleotide sub-
stitution rate to be around 2.5 SNPs per genome per year
[95% CI: 0.87–4.89] (4.18107SNPs/site/year), and thereby
calculate divergence times for the isolates in the ST2 clade
(fig. 2). The date of the most recent common ancestor was
found to be around 30 years ago, and the dissemination of
this ST within and across hospitals has therefore taken place
since this date (fig. 2). Comparing the recombination rate
(0.04 per genome per year) with the substitution rate for
ST2, we can conclude that recombination has played a rela-
tively minor role in shaping recent diversity of K. oxytoca.
Recent recombination in K. oxytoca was found to generally
involve the deletion or insertion of small genomic regions,
with an average size of 11.79kb, but which could be up to
41kb (0.6% of the whole genome; see supplementary table
S2, Supplementary Material online). Most recombination ap-
pears to occur in regions encoding bacteriophage genes,
along with genes involved in conjugal transfer (see supple-
mentary table S2, Supplementary Material online). In addition,
genes involved in the SOS response such as the Lex transcrip-
tional repressor and DNA polymerase subunit V, and also mer-
cury resistance proteins, membrane proteins and fimbrial
proteins were affected by recent recombination events. The
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recombination of membrane and fimbrial proteins indicates
diversifying selection on surface structures, suggestive of se-
lection due to interaction with the host immune system.
The genetic diversity of K. oxytoca is also reflected in the
size of the accessory genome. The pan-genome of K. oxytoca
contained 17,729 genes, of which 2,951 genes were in the
core genome (in>99% of isolates), 376 genes were in the
soft core genome (in>95% and<99% of isolates), 4,166
genes were in the shell genome (in>15% and<95% isolates)
and 10,236 genes were in the cloud genome (in<15% of
isolates; fig. 3A). This large accessory genome is likely to pro-
vide K. oxytoca with the genetic repertoire required for adap-
tation to multiple habitats. The pattern of the presence of
accessory genes demonstrated a high level of concordance
between the core genome tree and a tree built from the pres-
ence/absence of accessory genes (P-value for the association
by Mantel test<0.001; fig. 3B). This suggests that each major
clade has a unique set of accessory genes, which could be
generated through early establishment of the accessory
genome, or by the dominant mode of gene exchange being
within clades (fig. 3A and B). Either would suggest that the
major clades may have specific niche adaptations. In line with
the distant phylogenetic relationship between the global
Klesbiella collection and K. oxytoca, the two populations ap-
peared to have a large set of core genes (1,399 genes for the
global K. pneumoniae complex population and 2,075 genes
for K. oxytoca), which were almost absent (in<10% of the
population) in the other population (fig. 3C). Furthermore, the
two populations harbored 66,857 accessory genes that were
present in <10% of both collections. Together, these reflect
the very distinct evolutionary forces that have shaped the ge-
nomic diversity of each species, and the likely distinct niches
they occupy. However, figure 3C also shows that K. oxytoca
and the K. pneumoniae complex species in the global collec-
tion do share a number of accessory genes that are variably
present in both populations, indicating some shared adapta-
tion to common niches. The list of shared accessory genes
within the dotted box in figure 2C, which are present in 20–
80% of the population of either collection, is provided in sup-
plementary table S3, Supplementary Material online. Within
this set of shared accessory genes, besides phage-related
genes, are genes involved in virulence and drug resistance
such as copper resistance proteins, various multidrug transpor-
ters, efflux pumps and iron transport proteins, suggesting that
these genes may confer an adaptive advantage in both
populations.
The sharing of gene pools between K. oxytoca and the K.
pneumoniae complex population is reflected in the distribu-
tion of some conjugative multidrug resistance plasmids that
also occur in the global K. pneumoniae complex population,
some of which (such as Kpn3) are known to carry antimicro-
bial resistance genes (Pitout et al. 1998; see supplementary
fig. S3A, Supplementary Material online). Moreover, these
plasmids tend to occur more frequently in the nosocomially-
acquired than in the community-acquired K. pneumoniae
complex, which is suggestive of the spread of similar multi-
drug resistance plasmids in hospital settings between the two
species (see supplementary fig. S3B, Supplementary Material
online). The distribution of K. pneumoniae virulence factors
also showed virulence factors that were widespread across the
MDR K. oxytoca population and may be present in strains
from all clades (see supplementary fig. S4, Supplementary
Material online). TheseK. pneumoniae virulence genes include
the fyuA and ybtAPTQ genes of the yersiniabactin gene clus-
ter, involved in iron acquisition (Lawlor et al. 2007), the ybbW
and allBCRAS genes of the allantoinase gene cluster, involved
in the metabolism of allatonin (Chou et al. 2004), and the
mrkAB genes that are involved in the production of man-
nose-resistant fimbriae and biofilm formation (Jagnow and
Clegg 2003). While our results indicate sharing with K. oxy-
toca of genes known to be involved in virulence of K. pneu-
moniae, whether these genes are actually involved in virulence
in K. oxytoca will need evidence from functional studies.
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FIG. 2.—Dated Bayesian phylogenetic tree for the ST2 clade, gener-
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Klebsiella oxytoca is known to have a similar antimicrobial
resistance profile to K. pneumoniae. Despite the variation in
the MICs for every antimicrobial (fig. 4A and see supplemen-
tary fig. S5, Supplementary Material online), at the phenotypic
level, there were different degrees of variation: our isolates
were extensively resistant to amoxicillin (S:0, I:0, R:41), cefur-
oxime (S:0, I:0, R:41) and piperacillin–tazobactam (S:3, I:7,
R:31). In contrast, resistance was less common for amoxicil-
lin–clavulanate (S:11, I:0, R:30; known to inhibit chromosom-
ally encoded beta-lactamases; Arakawa et al. 1989),
ciprofloxacin (S:9, I:10, R:22) and ceftazidime (S:26, I:9, R:6).
Our isolates were extensively susceptible to imipenem (S:41,
I:0, R:0), gentamicin (S:33, I:3, R:5), and tigecycline (S:20, I:13,
R:5; fig. 4A and B). As expected, we observed a strong corre-
lation between MIC values for some antimicrobials, most no-
tably antimicrobials with similar resistance mechanisms (see
supplementary fig. S6, Supplementary Material online). For
every antimicrobial where we analyzed the relationships be-
tween elevated resistance level (MICs) and the genotype, if
there was variation in resistance phenotype, then these were
spread across the phylogenetic tree, implying that mecha-
nisms increasing resistance may be acquired independently
by sub-clades (fig. 4A). However, the MICs for beta-lactams
seemed to be higher for the KoII group than for the KoI group
(see supplementary fig. S7, Supplementary Material online).
This difference might be due to expression levels rather than
the enzyme type (Gheorghiu et al. 1997; Livermore 1995)
because besides blaOXY, which was not linked with resistance
in our dataset, only one isolate seemed to have gained blaSHV
(an ESBL) and blaLEN, which are specific toK. pneumoniae, and
nine isolates had blaTEM (fig. 5A). For the majority of other
antimicrobial resistance genes, the genes are also found in the
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global K. pneumoniae complex population and they occurred
more frequently in the nosocomial sub-population than the
community sub-populations of the K. pneumoniae complex
(fig. 5B). The low frequency of known ESBLs suggests that
beta-lactam resistance may be driven by other mechanisms
that alter the expression level or the structure of existing beta-
lactamases in K. oxytoca, rather than the acquisition of novel
beta-lactamases. This potentially includes occurrence of chro-
mosomal mutations or different expression levels of penicillin-
binding protein AmpH, which is present in every isolate.
The pattern of acquisition of other known antibiotic resis-
tance determinants indicates that antimicrobial resistance de-
terminants have been acquired independently across the
population and their presence is linked with elevated MICs
for some clades (fig. 5A). Increased tetracycline resistance
was observed in sub-clades of ST2 and was associated with
the presence of copies of tetracycline efflux tetA genes (figs.
4A and 5A). In addition, gentamicin resistance genes, in par-
ticular strA and strB phosphotransferase genes have been ac-
quired in a few isolates throughout the phylogenetic tree and
exhibit strong association with elevated MICs for gentamicin
and gentamicin resistant phenotype, showing enzymatic re-
sistance is responsible for gentamicin resistance in K. oxytoca
(fig. 5A; P-value< 0.01 obtained from Student’s t-test for the
significance of association between gene presence/absence
variable (predictor variable) and MICs (dependent variable) in
a linear regression model). Besides the efflux pump-encoding
oqxB gene, present in almost every isolate and the oqxA gene
present only in isolates in the KoVI clade, two KoI isolates
appear to have the quinolone resistance gene qnrS, but
none of these genes seem to be associated with variations
in the MICs for ciprofloxacin. In contrast the non-synonymous
mutations at the known codon position 83 of DNA gyrase A
(Gruger et al. 2004), which is present in 95% of resistant
strains and absent in 90% of susceptible/intermediate strains,
appear to primarily account for ciprofloxacin resistance.
Furthermore, specific non-synonymous mutations at position
D87 of DNA gyrase A and at position E461 of DNA topoisom-
erase IV subunit B also occurred in ciprofloxacin resistant iso-
lates. Given the decreased susceptibility to ciprofloxacin that
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has been reported across Europe (Brisse et al. 2000), the mul-
tiple independent emergence and spread of resistance deter-
minants could greatly limit the use of ciprofloxacin to treat K.
oxytoca.
Discussion
In this study we used whole genome sequencing to elucidate
the population structure of multidrug resistant K. oxytoca, as
the second most clinically prevalent species of the Klebsiella
genus (Broberg et al. 2014). Our results show that the MDR K.
oxytoca population is highly diverse and that some clades have
undergone recent expansion in our population. Despite the
high level of divergence between K. oxytoca and the K. pneu-
moniae complex, similar virulence and antimicrobial resistance
mechanisms appear to operate within either species.
Our results provide evidence for the existence of a shared
gene pool and the role of convergent evolution in developing
similar virulence and, to a lesser degree, antimicrobial resis-
tance mechanisms in these two closely related species,
presumably in the face of similar ecological challenges. This
suggests that utilizing a shared gene pool via horizontal gene
transfer may facilitate adaptation to new environments across
these species concurrently, as has been proposed in other
bacterial species (Cooper 2007; Wiedenbeck and Cohan
2011), which in turn suggests that these organisms may
occupy converging niches. Understanding whether or not
these mechanisms originate from the ancestral state (parallel-
ism) or have been acquired from unrelated sources (Stern
2013) will require a broader sampling from other Klebsiella
species and also from more closely related intermediate spe-
cies between K. oxytoca and K. pneumoniae. In doing so we
will be able to better understand the evolutionary forces that
delineate Klebsiella species, in particular in connection with
specific and similar habitats that each species occupies.
As an opportunistic pathogen, K. oxytoca is known to have
environmental sources and therefore the environment may
serve as a potential reservoir for MDR K. oxytoca. This not
only includes contaminated hospital equipment, but also the
carriage of the pathogen by healthy people between distant
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geographical regions and subsequent introduction into hospi-
tals (Decre et al. 2004; Lowe et al. 2012). Our observation of
the rapid dissemination of one K. oxytoca clone across what
are geographically distant hospitals suggests that transmission
may not be directly between hospitals, but may involve car-
riage in the general population. This would suggest that MDR
strains have already spread across the country and on some
occasions will give rise to infections within hospital settings.
This epidemiological pattern is what would be expected for a
commensal organism and makes outbreak control more dif-
ficult than for true nosocomial pathogens.
In this study we have used whole genome sequencing to
conduct a comparative genomic analysis for two closely re-
lated opportunistic pathogens. Compared with K. pneumo-
niae, K. oxytoca has been less well studied and this study has
provided the very first insights into the population diversity of
K. oxytoca. To understand the broader patterns of K. oxytoca
epidemiology and evolution; however, a collection from a
wider geographical area that also contains drug susceptible
strains will be required. This will serve as the basis to under-
stand the population structure of K. oxytoca and elucidate the
global epidemiology of K. oxytoca.
Supplementary Material
Supplementary data are available at Genome Biology and
Evolution online.
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